BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+39.76%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.54B
AUM Growth
+$2.54B
Cap. Flow
-$14.3M
Cap. Flow %
-0.56%
Top 10 Hldgs %
54.04%
Holding
74
New
12
Increased
15
Reduced
24
Closed
6

Top Buys

1
OLMA icon
Olema Pharmaceuticals
OLMA
$320M
2
AMRN
Amarin Corp
AMRN
$47.2M
3
FDMT icon
4D Molecular Therapeutics
FDMT
$45.8M
4
PTGX icon
Protagonist Therapeutics
PTGX
$38.3M
5
LXRX icon
Lexicon Pharmaceuticals
LXRX
$37.5M

Top Sells

1
SWTX
SpringWorks Therapeutics
SWTX
$164M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
$119M
3
CLDX icon
Celldex Therapeutics
CLDX
$45.5M
4
ELDN icon
Eledon Pharmaceuticals
ELDN
$42.4M
5
REPL icon
Replimune Group
REPL
$38.9M

Sector Composition

1 Healthcare 98.24%
2 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PHXM
51
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$6.12M 0.24%
625,000
– –
GLMD icon
52
Galmed Pharmaceuticals
GLMD
$6.96M
$5.6M 0.22%
1,799,694
– –
EUCRU
53
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$5.33M 0.21%
+500,000
New +$5.33M
FLACU
54
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$5.21M 0.2%
+500,000
New +$5.21M
CRIS icon
55
Curis
CRIS
$20.5M
$5.14M 0.2%
626,945
-3,023,055
-83% -$24.8M
XFOR icon
56
X4 Pharmaceuticals
XFOR
$77.9M
$5.1M 0.2%
792,892
– –
FVAM
57
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$5.09M 0.2%
+500,000
New +$5.09M
PHAT icon
58
Phathom Pharmaceuticals
PHAT
$841M
$5.01M 0.2%
150,787
-171,311
-53% -$5.69M
RGLS
59
DELISTED
Regulus Therapeutics
RGLS
$4.56M 0.18%
3,376,207
+158,727
+5% +$214K
FWP
60
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$4.56M 0.18%
647,299
– –
VIRX
61
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.44M 0.14%
1,727,308
– –
JYAC
62
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$3.09M 0.12%
+300,000
New +$3.09M
RZLT icon
63
Rezolute
RZLT
$624M
$2.36M 0.09%
+190,814
New +$2.36M
SNCE
64
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.06M 0.04%
+100,000
New +$1.06M
FSTX
65
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$255K 0.01%
25,844
-915,327
-97% -$9.03M
VRDN icon
66
Viridian Therapeutics
VRDN
$1.56B
$160K 0.01%
+9,747
New +$160K
PANA.U
67
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$126K 0.01%
9,837
-790,163
-99% -$10.1M
SWTX
68
DELISTED
SpringWorks Therapeutics
SWTX
$4K ﹤0.01%
50
-2,053,941
-100% -$164M
ANAB icon
69
AnaptysBio
ANAB
$577M
– –
-1,227,405
Closed -$18.1M
BLRX
70
BioLineRX
BLRX
$16M
– –
-1,686,375
Closed -$2.77M
CLDX icon
71
Celldex Therapeutics
CLDX
$1.46B
– –
-3,066,797
Closed -$45.5M
EXEL icon
72
Exelixis
EXEL
$10B
– –
-15,300
Closed -$374K
REPL icon
73
Replimune Group
REPL
$461M
– –
-1,691,834
Closed -$38.9M
EVLO
74
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
– –
-1,300,000
Closed -$6.85M
1 2
3